Wow, I've never tried that much before. I'll try it out
you will love but if you add another form of carnitine low the dose of ALCAR
ALCAR Therapeutic Uses
L-Carnitine - ALCAR Angina
Carnitine might be a good addition to standard therapy for angina. In one controlled study, 200 individuals with angina (the exercise-induced variety) took either 2 g daily of L-carnitine or were left untreated. All the study participants continued to take their usual medication for angina. Those taking carnitine showed improvement in several measures of heart function, including a significantly greater ability to exercise without chest pain.70 They were also able to reduce the dosage of some of their heart medications (under medical supervision) as their symptoms decreased.
Another trial that did use a double-blind, placebo-controlled design tested L-carnitine in 52 individuals with angina, and found evidence of benefit. In addition, several small studies (some of them double-blind) tested propionyl-L-carnitine for the treatment of angina, and also found evidence of benefit.
ALCAR and Hardening of The Arteries
People with advanced hardening of the arteries, or atherosclerosis, often have difficulty walking due to lack of blood flow to the legs. Pain may develop after walking less than half a block. Although carnitine does not increase blood flow, it appears to improve the muscle's ability to function under difficult circumstances.
A 12-month double-blind placebo-controlled trial of 485 patients with intermittent claudication evaluated the potential benefits of propionyl-L-carnitine. Participants with relatively severe disease showed a 44% improvement in walking distance as compared to placebo. However, no improvement was seen in those with mild disease. Another double-blind study followed 245 people and also found benefit.
Similar results have been seen in most but not all other studies of L-carnitine or propionyl-L-carnitine. Propionyl-L-carnitine may be more effective for intermittent claudication than plain carnitine.
L-Carnitine - ALCAR Congestive Heart Failure
Several small studies have found that carnitine, often in the form of propionyl-L-carnitine, can improve symptoms of congestive heart failure. In one trial, benefits were maintained for 60 days after treatment with carnitine was stopped.
ALCAR After a Heart Attack
Carnitine may help reduce death rate after a heart attack. In a 12-month placebo-controlled study, 160 individuals who had experienced a heart attack received 4 g of L-carnitine daily or placebo, in addition to other conventional medication. The mortality rate in the treated group was significantly lower than in the placebo group, 1.2% versus 12.5%, respectively. There were also improvements in heart rate, blood pressure, angina (chest pain), and blood lipids. A larger double-blind study of 472 people found that carnitine may improve the chances of survival if given within 24 hours after a heart attack. Note: Carnitine is used along with conventional treatment, not as a substitute for it.
Chronic Obstructive Pulmonary Disease (COPD)
Evidence from three double-blind placebo-controlled studies enrolling a total of 49 individuals suggests that L-carnitine can improve exercise tolerance in COPD, presumably by improving muscular efficiency in the lungs and other muscles.
L-Carnitine - ALCAR and Alzheimer's Disease
Numerous double- or single-blind studies involving a total of more than 1,400 people have evaluated the potential benefits of acetyl-L-carnitine in the treatment of Alzheimer's disease and other forms of dementia. Early studies found some evidence of benefit, although it was generally quite modest. However, the two most recent and best-designed studies found no benefit.
A double-blind placebo-controlled trial that enrolled 431 participants for 1 year found no significant improvement at all in the group treated with acetyl-L-carnitine. A close look at the results appeared to suggest some benefit in individuals who developed Alzheimer's disease at a particularly young age. However, when this possibility was tested in a 1-year double-blind placebo-controlled trial of 229 patients with early-onset Alzheimer's, no benefits were seen.
L-Carnitine - ALCAR and Mild Depression
A double-blind study of 60 seniors with mild depression found that treatment with 3 g of carnitine daily over a 2-month period significantly improved symptoms as compared to placebo. Positive results were seen in another study as well.
L-Carnitine - Alcar and Hyperthyroidism
Enlargement of the thyroid (goiter) can be due to many causes, including cancer and iodine deficiency. In some cases, thyroid enlargement occurs without any known cause, so-called benign goiter.
Treatment of benign goiter generally consists of taking thyroid hormone pills. This causes the thyroid gland to become less active, and the goiter shrinks. However, there may be undesirable effects as well. Symptoms of hyperthyroidism (too much thyroid hormone) can develop, including heart palpitations, nervousness, weight loss, and bone breakdown.
A double-blind, placebo-controlled trial found evidence that use of L-carnitine could alleviate many of these symptoms. This 6-month study evaluated the effects of L-carnitine in 50 women who were taking thyroid hormone for benign goiter. The results showed that a dose of 2 or 4 g of carnitine daily protected participants' bones and reduced other symptoms of hyperthyroidism.
Carnitine is thought to affect thyroid hormone by blocking its action in cells. This suggests a potential concern: Carnitine might be harmful for people who have low or borderline thyroid levels to begin with. This possibility has not been well explored as yet.
ALCAR and Peyronie's Disease
Peyronie's disease is an inflammatory condition of the penis that develops in stages. In the first stage, penile pain occurs with erection; next, the penis becomes curved; finally, erectile dysfunction may occur. Many medications have been tried for Peyronie's disease, with some success. One such drug is tamoxifen (better known as a treatment to prevent breast cancer recurrence.) A 3 month, double-blind study compared the effectiveness of acetyl-L-carnitine (1 gram twice daily) against tamoxifen; the study enrolled 15 men in the first stage of Peyronie's disease and 33 men in the second stage. The result indicated that acetyl-L-carnitine reduced penile curvature while tamoxifen did not; the supplement also reduced pain and slowed disease progression to a greater extent than the drug. Furthermore, while the drug caused various side effectsa and the supplement caused none.
). I got hooked on Testabolan (the original) years ago before I was a rep and liked V2 even better. Guess it was about time to up the ante with another improvement!